Sean Li, MD
Pain Medicine · Shrewsbury, NJNPI 1386623130
Payments from drug & device makers
Across 2,938 payments — averaging $746.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avanos Medical$506K
- SPR Therapeutics, Inc$463K
- Nevro Corp.$282K
- Saluda Medical Americas, Inc.$195K
- Boston Scientific$159K
- Averitas Pharma Inc.$75K
- plus $514K from 54 others
Across 20 payments — averaging $84.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Saluda Medical Americas, Inc.$1K
- Nevro Corp.$500
What the payments were for
- Consulting fees$588,60348%
- Speaking & faculty fees$397,94132%
- Travel & lodging$136,67911%
- Food & beverage$80,9587%
- Education$31,9113%
- Gifts$340%
- Entertainment$990%
- Ownership interest$1,6010%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRINT PNS System$142,237
- Senza Spinal Cord Stimulation System$116,434
- Evoke SCS$95,434
- Omnia$84,656
- SUPERION$77,707
- COOLIEF$68,654
- mild Device Kit$66,988
- Superion ISS$65,367
- PAINTEQ$48,019
- iFuse Implant$47,184
- Nalu Neurostimulation System$46,803
- Evoke$44,167
- Qutenza$32,724
- Prospera$28,574
- Superion Indirect Decompression System$26,248
- COOLIEF* COOLED RADIOFREQUENCY$25,621
- VERIFLEX$22,302
- PROCLAIM$17,307
- COOLED RFA$17,045
- Neuromodulation Dspsbls and Accs$13,717
How this compares
$2,194,021 in reported general payments places this provider in the 95th percentile of 256 pain medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 194 | $1,572 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 71 | $966 |
| Methylprednisolone | 60 | $448 |
| Pregabalin | 28 | $375 |
| Cephalexin | 42 | $222 |
| Duloxetine Hcl | 15 | $216 |
| Meloxicam | 73 | $185 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $115 |
| Cyclobenzaprine Hcl | 12 | $110 |
| Amitriptyline Hcl | 16 | $89 |
| Tramadol Hcl | 18 | $73 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 15 | $57 |
| Tizanidine Hcl | 14 | $48 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Shrewsbury
- Peter StaatsShrewsbury$362K
- Kulbir WaliaShrewsbury$7K
- Matthias WiederholzLawrenceville$866K
- Todd StitikNewark$370K
- Warren GraceEdison$158K
- Caitlin InnerfieldHaddonfield$97K
- Rajat SekharWhiting$84K
- Anson MoiseEnglewood$78K
- Samyadev DattaHackensack$65K
- Pavli DemianSomerset$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.